Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Triplitt: Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes. (0.10 sec) 

Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes


C Triplitt, CA Alvarez - Diabetes Spectrum, 2008 - Am Diabetes Assoc
Cardiovascular disease (CVD) is a common complication of diabetes; nearly 80% of
all people with diabetes will die from macrovascular complications.
Dyslipidemia, hypertension, hypercoagulability, poor glycemic control, ...
Related articles - All 2 versions

The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic …


ALID Diabetes - Diabetes care, 2001 - ncbi.nlm.nih.gov
OBJECTIVE: In patients with type 2 diabetes, intensive glucose regulation,
although effective for microangiopathy, has not been shown to have unambiguous
preventive effects on the occurrence of cardiovascular disease. Patients ...
Cited by 5 - Related articles

[CITATION] Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European …


K Kay-Tee, N Wareham, R Luben, S Bingham, … - British Medical Journal, 2001
Cited by 5 - Related articles

[CITATION] Multifactorial interventional and cardiovascular disease in patient with type 2 diabetes


P Goede, P Vedel, N Larsen, GVH Jensen, HH … - N Engl J Med, 2003
Cited by 6 - Related articles

Alterations of adenine nucleotide metabolism and function of blood platelets in patients with …


A Michno, H Bielarczyk, T Pawełczyk, A … - Diabetes, 2007 - Am Diabetes Assoc
Increased activity of blood platelets contributes to vascular complications in
patients with diabetes. The aim of this work was to investigate whether
persisting hyperglycemia in diabetic patients generates excessive ...
Cited by 6 - Related articles - BL Direct - All 5 versions

Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis


M McAdams, J Staffa, G Dal Pan - Pharmacoepidemiology and drug safety, 2008 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 4 - Related articles - BL Direct - All 2 versions

Cardiovascular risk management in type 2 diabetes: from clinical trials to clinical practice


K Cusi - The Endocrinologist, 2001 - journals.lww.com
• Recognize the prevalence and severity of athero- sclerotic cardiovascular
disease in patients with type 2 diabetes mellitus and the corresponding need to
modify risk factors at an early stage. • Recall the effects of treating ...
Cited by 11 - Related articles - BL Direct - All 2 versions

[CITATION] American College of Endocrinology consensus statement on guidelines for glycemic control


RH Cobin, JA Davidson, OP Ganda, A Garber, … - Endocr Pract, 2002
Cited by 12 - Related articles

[CITATION] The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the …


JR Gavin, K Alberti, MB Davidson, RA … - Diabetes Care, 1997
Cited by 15 - Related articles

Controlling lipid levels in diabetes


MR Taskinen - Acta Diabetologica, 2002 - Springer
Abstract Coronary heart disease (CHD) is associated with a 2- to 4-times greater
risk of morbidity and mortality in patients with type 2 diabetes than in
non-diabetic individu- als. Dyslipidaemia is an important CHD risk factor ...
Cited by 15 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google